# Liraglutide and Cardio-Metabolic Risk Markers

> **NCT01715428** · — · COMPLETED · sponsor: **University of Palermo** · enrollment: 300 (actual)

## Conditions studied

- Type-2 Diabetes

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT01715428
- **Lead sponsor:** University of Palermo
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2012-06
- **Primary completion:** 2015-12
- **Final completion:** 2015-12
- **Target enrollment:** 300 (ACTUAL)
- **Last updated:** 2017-11-22


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01715428

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01715428, "Liraglutide and Cardio-Metabolic Risk Markers". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT01715428. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*